Literature DB >> 21593238

Serological responses to experimental Norwalk virus infection measured using a quantitative duplex time-resolved fluorescence immunoassay.

Owen Kavanagh1, Mary K Estes, Amanda Reeck, Ravikiran M Raju, Antone R Opekun, Mark A Gilger, David Y Graham, Robert L Atmar.   

Abstract

A quantitative duplex time-resolved fluorescence assay, dissociation-enhanced lanthanide fluorescent immunoassay (DELFIA), was developed to measure Norwalk virus (NV)-specific IgA and IgG antibodies simultaneously. The duplex assay showed superior performance by detecting seroconversion following experimental NV infection at an earlier time point than a reference total immunoglobulin enzyme-linked immunosorbent assay (ELISA).

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21593238      PMCID： PMC3147314          DOI： 10.1128/CVI.00039-11

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  17 in total

1.  Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein.

Authors:  X Jiang; M Wang; D Y Graham; M K Estes
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

Review 2.  The epidemiologic and clinical importance of norovirus infection.

Authors:  Robert L Atmar; Mary K Estes
Journal:  Gastroenterol Clin North Am       Date:  2006-06       Impact factor: 3.806

3.  Detection of immunoglobulin M (IgM), IgA, and IgG Norwalk virus-specific antibodies by indirect enzyme-linked immunosorbent assay with baculovirus-expressed Norwalk virus capsid antigen in adult volunteers challenged with Norwalk virus.

Authors:  J J Gray; C Cunliffe; J Ball; D Y Graham; U Desselberger; M K Estes
Journal:  J Clin Microbiol       Date:  1994-12       Impact factor: 5.948

4.  Norwalk virus infection of volunteers: new insights based on improved assays.

Authors:  D Y Graham; X Jiang; T Tanaka; A R Opekun; H P Madore; M K Estes
Journal:  J Infect Dis       Date:  1994-07       Impact factor: 5.226

5.  Correlation of patient immune responses with genetically characterized small round-structured viruses involved in outbreaks of nonbacterial acute gastroenteritis in the United States, 1990 to 1995.

Authors:  J S Noel; T Ando; J P Leite; K Y Green; K E Dingle; M K Estes; Y Seto; S S Monroe; R I Glass
Journal:  J Med Virol       Date:  1997-12       Impact factor: 2.327

6.  Synthesis, characterization, and application of Eu(III), Tb(III), Sm(III), and Dy(III) lanthanide chelate nanoparticle labels.

Authors:  Petri Huhtinen; Mirja Kivelä; Outi Kuronen; Virve Hagren; Harri Takalo; Heikki Tenhu; Timo Lövgren; Harri Härmä
Journal:  Anal Chem       Date:  2005-04-15       Impact factor: 6.986

7.  Detection of Norwalk virus and other genogroup 1 human caliciviruses by a monoclonal antibody, recombinant-antigen-based immunoglobulin M capture enzyme immunoassay.

Authors:  J P Brinker; N R Blacklow; M K Estes; C L Moe; K J Schwab; J E Herrmann
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

8.  Comparison of the reactivities of baculovirus-expressed recombinant Norwalk virus capsid antigen with those of the native Norwalk virus antigen in serologic assays and some epidemiologic observations.

Authors:  K Y Green; J F Lew; X Jiang; A Z Kapikian; M K Estes
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

9.  Simultaneous quadruple-label fluorometric immunoassay of thyroid-stimulating hormone, 17 alpha-hydroxyprogesterone, immunoreactive trypsin, and creatine kinase MM isoenzyme in dried blood spots.

Authors:  Y Y Xu; K Pettersson; K Blomberg; I Hemmilä; H Mikola; T Lövgren
Journal:  Clin Chem       Date:  1992-10       Impact factor: 8.327

10.  Antigenic mapping of the recombinant Norwalk virus capsid protein using monoclonal antibodies.

Authors:  M E Hardy; T N Tanaka; N Kitamoto; L J White; J M Ball; X Jiang; M K Estes
Journal:  Virology       Date:  1996-03-01       Impact factor: 3.616
View more
  12 in total

1.  Serological Correlates of Protection against a GII.4 Norovirus.

Authors:  Robert L Atmar; David I Bernstein; G Marshall Lyon; John J Treanor; Mohamed S Al-Ibrahim; David Y Graham; Jan Vinjé; Xi Jiang; Nicole Gregoricus; Robert W Frenck; Christine L Moe; Wilbur H Chen; Jennifer Ferreira; Jill Barrett; Antone R Opekun; Mary K Estes; Astrid Borkowski; Frank Baehner; Robert Goodwin; Anthony Edmonds; Paul M Mendelman
Journal:  Clin Vaccine Immunol       Date:  2015-06-03

2.  Mucosal and Cellular Immune Responses to Norwalk Virus.

Authors:  Sasirekha Ramani; Frederick H Neill; Antone R Opekun; Mark A Gilger; David Y Graham; Mary K Estes; Robert L Atmar
Journal:  J Infect Dis       Date:  2015-01-29       Impact factor: 5.226

3.  Ultra-sensitive immunoassay biosensors using hybrid plasmonic-biosilica nanostructured materials.

Authors:  Jing Yang; Le Zhen; Fanghui Ren; Jeremy Campbell; Gregory L Rorrer; Alan X Wang
Journal:  J Biophotonics       Date:  2014-09-25       Impact factor: 3.207

4.  Seroepidemiology of norovirus-associated travelers' diarrhea.

Authors:  Nadim J Ajami; Owen V Kavanagh; Sasirekha Ramani; Sue E Crawford; Robert L Atmar; Zhi-Dong Jiang; Pablo C Okhuysen; Mary K Estes; Herbert L DuPont
Journal:  J Travel Med       Date:  2014 Jan-Feb       Impact factor: 8.490

5.  Flow-through microfluidic immunosensors with refractive index-matched silica monoliths as volumetric optical detection elements.

Authors:  M S Wiederoder; E L Kendall; J-H Han; R G Ulrich; D L DeVoe
Journal:  Sens Actuators B Chem       Date:  2017-07-21       Impact factor: 7.460

6.  Determination of the 50% human infectious dose for Norwalk virus.

Authors:  Robert L Atmar; Antone R Opekun; Mark A Gilger; Mary K Estes; Sue E Crawford; Frederick H Neill; Sasirekha Ramani; Heather Hill; Jennifer Ferreira; David Y Graham
Journal:  J Infect Dis       Date:  2013-11-18       Impact factor: 5.226

7.  Norovirus vaccine against experimental human Norwalk Virus illness.

Authors:  Robert L Atmar; David I Bernstein; Clayton D Harro; Mohamed S Al-Ibrahim; Wilbur H Chen; Jennifer Ferreira; Mary K Estes; David Y Graham; Antone R Opekun; Charles Richardson; Paul M Mendelman
Journal:  N Engl J Med       Date:  2011-12-08       Impact factor: 91.245

8.  Serum hemagglutination inhibition activity correlates with protection from gastroenteritis in persons infected with Norwalk virus.

Authors:  Rita Czakó; Robert L Atmar; Antone R Opekun; Mark A Gilger; David Y Graham; Mary K Estes
Journal:  Clin Vaccine Immunol       Date:  2011-12-21

9.  Antibody responses to norovirus genogroup GI.1 and GII.4 proteases in volunteers administered Norwalk virus.

Authors:  Nadim J Ajami; Meagan A Barry; Berenice Carrillo; Zana Muhaxhiri; Frederick H Neill; B V Venkataram Prasad; Antone R Opekun; Mark A Gilger; David Y Graham; Robert L Atmar; Mary K Estes
Journal:  Clin Vaccine Immunol       Date:  2012-10-03

10.  Replication of Human Norovirus RNA in Mammalian Cells Reveals Lack of Interferon Response.

Authors:  Lin Qu; Kosuke Murakami; James R Broughman; Margarita K Lay; Susana Guix; Victoria R Tenge; Robert L Atmar; Mary K Estes
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.